| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2024 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 98.01B | 98.16B | 98.64B | 90.94B | 91.98B | 98.85B |
| Gross Profit | 36.83B | 36.85B | 37.31B | 34.89B | 35.54B | 39.09B |
| EBITDA | 1.07B | -228.00M | 2.32B | 2.32B | 2.31B | 3.85B |
| Net Income | -1.79B | -3.80B | -67.00M | -477.00M | 108.00M | 905.00M |
Balance Sheet | ||||||
| Total Assets | 69.25B | 64.65B | 69.72B | 65.00B | 65.20B | 64.21B |
| Cash, Cash Equivalents and Short-Term Investments | 6.13B | 4.58B | 4.18B | 2.96B | 2.93B | 3.51B |
| Total Debt | 29.36B | 29.27B | 32.35B | 27.48B | 26.74B | 24.61B |
| Total Liabilities | 46.23B | 43.58B | 44.56B | 39.22B | 38.61B | 37.37B |
| Stockholders Equity | 23.02B | 21.06B | 25.16B | 25.78B | 26.59B | 26.83B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.79B | -823.00M | -523.00M | -1.99B | -2.14B |
| Operating Cash Flow | 0.00 | 3.45B | 649.00M | 1.78B | 965.00M | -309.00M |
| Investing Cash Flow | 0.00 | -565.00M | -3.60B | -2.12B | -3.20B | -2.02B |
| Financing Cash Flow | 0.00 | -3.04B | 4.28B | 165.00M | 1.67B | 1.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥370.75B | 8.84 | ― | 1.35% | 16.41% | 34.09% | |
66 Neutral | ¥273.81B | 11.66 | 11.17% | 2.61% | 5.12% | 12.69% | |
65 Neutral | ¥219.96B | 18.16 | ― | 2.23% | 3.35% | 7.82% | |
64 Neutral | ¥444.52B | 9.24 | 4.18% | 2.57% | 1.79% | 7.00% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | ¥263.58B | 19.39 | ― | 2.72% | 2.37% | 39.41% | |
47 Neutral | ¥23.87B | -2.04 | ― | 4.61% | -0.49% | -5568.81% |